Vivax Working Group

2-4 March, 2013Bali, Indonesia

Vivax Working Group Meeting

Program

Workshop: The threat of antimalarial resistance to the elimination of malaria

  • Welcome to Indonesia – Dr Ferdinand Laihad, Chair of the National Malaria Control & Elimination Committee, Indonesia
  • Introduction to the workshop
  • The emerging threat of artemisinin resistance
  • Detecting artemisinin resistance in falciparum malaria
  • The spread of artemisinin resistance: results from the TRAC trial
  • Tracking Antimalarial Drug Resistance
  • Laboratory markers for drug resistance
  • New in vitro tests to assess artemisinin drug sensitivity in P. falciparum
  • Understanding artemisinin resistance in falciparum malaria
  • Artemisinin resistance in Plasmodium falciparum: A process linked to dormancy
  • Understanding the mechanisms of drug action and parasite resistance
  • Treatment and elimination of artemisinin resistant falciparum malaria
  • Treatment Options
  • Feedback from the report on the Artemisinin Resistance
  • Mathematical models of elimination strategies
  • Elimination strategies for malaria – role in antimalarial resistance: hotspots and hot-pops (Where and who are they? How do we find them? How can we target them? How do we evaluate it?)
  • Antimalarial resistance: country perspectives (Cambodia, Thailand, Vietnam, Indonesia, Malaysia, Philippines)
  • Drug resistant P. vivax - phenotypic characterisation
  • The emergence and spread of CQR P. vivax
  • Defining Antimalarial Efficacy in P. vivax.
  • Ex vivo drug susceptibility testing in P. vivax.
  • Novel in vitro drug studies in P. vivax.
  • Molecular characterisation of drug resistance
  • Genotyping of P. vivax clinical trials
  • Identifying candidate markers of drug resistance
  • Molecular Studies of P. vivax
  • Discussion on surveillance and elimination of antimalarial resistance
  • Concluding comments and wrap up

Vivax Working Group Meeting

  • The APMEN capacity building programme
  • Introduction to the APMEN Country Partner Technical Development Program
  • Research Update: Feedback from Investigators
  • Business Meeting: Review of the vivax working group progress, Proposed 2013 Workplan, Revisiting APMEN VxWG Research Priorities 

Meeting Materials

Back